Our therapeutic portfolio is built around high-demand, clinically relevant segments that address the growing burden of chronic and acute diseases. As a focused offline pharmaceutical organization, we ensure consistent availability, strong distribution support, and quality-assured formulations across core therapy areas including diabetology, cardiology, anti-infectives, gastrointestinal care, and nutritional supplements. Some of our products are given below.
Anti-Diabetic Range
Diabetes management requires precision, continuity, and reliable access to anti-diabetic medications. Our Anti-Diabetic portfolio includes advanced combination and single-molecule formulations designed to support effective glycemic control.
Key brands in this segment include Metazen GP1™, Metazen Trio™, Metazen Forte GP1™, and Sitanix™. These formulations are positioned to address varying stages of Type 2 diabetes management, supporting physicians in tailoring therapy based on patient requirements.
By maintaining strong supply chain discipline and demand forecasting, we ensure uninterrupted availability of these essential chronic care medications, enabling pharmacies and healthcare providers to deliver consistent diabetes management solutions.
Anti-Hypertensive & Cardiovascular Care
Cardiovascular disorders remain one of the leading health concerns globally. Our Anti-Hypertensive range is structured to support comprehensive blood pressure and lipid management strategies.
Our key cardiovascular care products include Cardizen 20™, Cardizen Beta™, and Lipozen™. These products are formulated to assist in blood pressure regulation, heart rate control, and lipid profile management, forming a strong foundation for long-term cardiovascular care.
Recognizing that hypertension and dyslipidemia therapies are lifelong commitments, we prioritize stock stability, proper storage standards, and efficient distribution to ensure patients have continuous access to prescribed regimens.
Anti-Infectives
Infection management remains a critical therapeutic priority across primary and secondary healthcare settings. Our antibiotic portfolio is led by Bactovia 625™, formulated to address a broad range of bacterial infections, and Nitrogyl-ER™, designed to provide sustained therapeutic action where clinically indicated.
We adhere strictly to regulatory norms governing antibiotic distribution, ensuring responsible supply practices, systematic batch monitoring, and expiry control. Through disciplined inventory management, we support healthcare professionals in delivering effective and compliant infection treatment.
Nutritional & Preventive Care
Preventive healthcare and nutritional support are increasingly recognized as essential components of overall treatment plans. Our multivitamin and supplementation range includes Zon D3™ and Vitazen-Plus™, designed to address vitamin deficiencies and support immunity, bone health, and metabolic function.
These formulations are widely recommended across age groups and are frequently prescribed as adjunct support in chronic disease management. We maintain consistent stock levels and proper storage conditions to meet growing demand in the wellness segment.
Others & Supportive Therapies
In addition to our core therapeutic segments, we offer supportive care formulations such as Rabivus™ and Pyrozen-SP™. These products are positioned to complement primary treatment protocols across various clinical indications and enhance overall therapeutic outcomes.
Our approach to this category emphasizes consistent availability, quality sourcing, and adherence to pharmaceutical distribution standards.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.